Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Source | Last Updated |
---|---|
LIPID MAPS Proteome Database (LMSD) | June 16, 2024 |
Main Class | Sub Class | LM ID | Name | LipidBank ID | KEGG ID | PubChem CID ▲ | ChEBI ID | Exact Mass | Formula |
---|---|---|---|---|---|---|---|---|---|
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AW02 |
|
44261149 | 2131.103551 | C96H170N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AW03 |
|
44261150 | 2159.134851 | C98H174N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AW04 |
|
44261151 | 2187.166151 | C100H178N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AW05 |
|
44261152 | 2215.197451 | C102H182N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AW06 |
|
44261153 | 2243.228751 | C104H186N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AW07 |
|
44261154 | 2213.181801 | C102H180N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AW08 |
|
44261155 | 2241.213101 | C104H184N4O47 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AX01 |
|
44261156 | 2249.130161 | C100H176N4O51 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AX02 |
|
44261157 | 2277.161461 | C102H180N4O51 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AX03 |
|
44261158 | 2305.192761 | C104H184N4O51 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AX04 |
|
44261159 | 2333.224061 | C106H188N4O51 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AX05 |
|
44261160 | 2361.255361 | C108H192N4O51 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AX06 |
|
44261161 | 2389.286661 | C110H196N4O51 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AX07 |
|
44261162 | 2359.239711 | C108H190N4O51 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AX08 |
|
44261163 | 2387.271011 | C110H194N4O51 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AY01 |
|
44261164 | 2452.209535 | C108H189N5O56 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AY02 |
|
44261165 | 2480.240835 | C110H193N5O56 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AY03 |
|
44261166 | 2508.272135 | C112H197N5O56 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AY04 |
|
44261167 | 2536.303435 | C114H201N5O56 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AY05 |
|
44261168 | 2564.334735 | C116H205N5O56 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AY06 |
|
44261169 | 2592.366035 | C118H209N5O56 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AY07 |
|
44261170 | 2562.319085 | C116H203N5O56 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AY08 |
|
44261171 | 2590.350385 | C118H207N5O56 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AZ01 |
|
44261172 | 1883.997962 | C86H153N3O41 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AZ02 |
|
44261173 | 1912.029262 | C88H157N3O41 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024